DERM vs NVST · rev $34.5M vs P/E 56, rev $1.44B
Journey Medical Corp (DERM) versus Envista Holdings Corp (NVST) — a side-by-side from cached financials, not a winner call.
Journey Medical Corp (DERM) is a drug manufacturers - specialty & generic company listed on US.
Envista Holdings Corp (NVST) is a medical instruments & supplies company listed on US.
Latest reported DERM revenue for 2026-06-30 was $34.5M. Net income was -$2.5M. DERM currently screens at market cap $163.1M.
Latest reported NVST revenue for 2026-07-03 was $1.44B. Net income was $92.4M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
DERM currently screens at market cap $163.1M. NVST currently screens at market cap $3.72B and trailing P/E 55.8.
Not investment advice. Open the DERM and NVST stock pages for the full models.
Not investment advice.